Northrop Grumman CORP /DE/

Northrop Grumman announced record backlog and increased 2026 financial guidance for sales and EPS following a 5% year-over-year sales increase in the second quarter.

Northrop Grumman Corporation's 2026 Annual Meeting saw shareholders overwhelmingly approve management's proposals, including director elections and auditor ratification, while rejecting a shareholder proposal for an independent board chair.

Northrop Grumman reported strong first quarter 2026 financial results, with sales up 4% and EPS significantly increasing, driven by robust demand and strategic agreements.

Northrop Grumman Corporation announced the election of Admiral Christopher W. Grady to its Board of Directors, alongside changes in executive compensation metrics and lead independent director.

Northrop Grumman reported a 10% sales increase in Q4 2025 and 2% for the full year, with record backlog and positive 2026 guidance.

Northrop Grumman Corporation announced the election of John Greene as its new Chief Financial Officer, effective January 7, 2026, succeeding Ken Crews.

Northrop Grumman reports a 5% increase in Q2 2026 sales to $10.88 billion, but net earnings fell 7% to $1.09 billion, impacted by a prior year gain on divestiture.

Northrop Grumman reported a significant increase in net earnings and diluted EPS for the first quarter of 2026, driven by strong performance across its segments.

Northrop Grumman reports a 4% increase in third-quarter sales and 10% diluted EPS growth, but year-to-date net earnings and free cash flow significantly declined, alongside ongoing B-21 program losses and a U.S. government shutdown.

Northrop Grumman reported a 12% decline in six-month net earnings to $1.655 billion, primarily due to a $477 million B-21 program loss provision, despite a strong second quarter boosted by a $231 million divestiture gain.

Northrop Grumman's Q1 2025 earnings declined significantly due to a loss provision on the B-21 program and lower sales in Space Systems, despite increased revenue in other segments.

Northrop Grumman's third quarter results show a 9% increase in net earnings and a 13% increase in diluted earnings per share, driven by higher sales and improved operating margins.

Northrop Grumman reports a 2% sales increase to $41.95 billion in 2025, but operating income growth is tempered by a significant B-21 program loss provision.

Northrop Grumman's 2024 results showcase a robust performance with increased sales, operating income, and a growing backlog, driven by strong demand and strategic realignments.

Northrop Grumman's 2023 10-K filing outlines the company's financial performance, strategic initiatives, and risk factors, including a significant charge on the B-21 program.

Mark A Welsh Iii, a Director of Northrop Grumman Corp /De/, sold 95 shares of common stock on August 3, 2026.

Northrop Grumman Director Marianne Catherine Brown reported a transaction involving the acquisition of 91 shares of common stock.

Northrop Grumman Director Arvind Krishna acquired 71 shares of common stock on June 30, 2026, as part of a deferred stock unit plan.

Director Mary Winston of Northrop Grumman Corp. reported a transaction involving common stock on May 20, 2026.

Mark A. Welsh III, a Director at Northrop Grumman Corp, reported a transaction involving common stock on May 20, 2026.

Northrop Grumman Director James S. Turley acquired 349 shares of common stock on May 20, 2026, as part of a deferred stock unit plan.

Northrop Grumman Corporation announced its 2026 Annual Meeting of Shareholders will be held virtually on May 20, 2026, detailing director nominees, executive compensation, and auditor ratification.

Northrop Grumman will hold its annual shareholders meeting virtually on May 21, 2025, encouraging shareholders to vote in advance.

Northrop Grumman announces its 2025 Annual Meeting of Shareholders and reports record backlog and sales growth in 2024.

Northrop Grumman will conduct its annual shareholders meeting online via live webcast on May 15, 2024.

Northrop Grumman's 2024 proxy statement outlines key proposals for the annual shareholder meeting, including director elections, executive compensation, and corporate governance matters.

Vanguard Capital Management has reported beneficial ownership of 10,248,540 shares, representing 7.22% of Northrop Grumman's common stock as of March 31, 2026.

The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Northrop Grumman Corp following an internal corporate realignment.

Capital International Investors has increased its beneficial ownership in Northrop Grumman Corp. to 8.6% of common stock, holding over 12.3 million shares.

The Vanguard Group has filed an Amendment No. 11 to its Schedule 13G, disclosing a continued passive beneficial ownership of 9.16% in Northrop Grumman Corp. common stock as of March 31, 2025.